Literature DB >> 8029401

Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation.

T C Winter1, K Takayasu, Y Muramatsu, H Furukawa, F Wakao, H Koga, M Sakamoto, S Hirohashi, P C Freeny.   

Abstract

PURPOSE: To determine the computed tomographic (CT) and magnetic resonance (MR) imaging appearances of early advanced hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Twenty-seven surgically resected cases of early advanced HCC were studied with CT, CT during arterial portography, CT arteriography, and MR imaging.
RESULTS: The sensitivity of standard CT (unenhanced, early, and late CT combined) for the detection of early advanced HCC was 81%, while that of standard MR imaging (T1- and T2-weighted MR imaging combined) was 83%. A nodule-in-nodule appearance was identified in approximately one-third to one-half of cases. Signal behavior of early and advanced components of early advanced HCC followed the expected behaviors of isolated early HCC and isolated advanced HCC, respectively. Tumor size was accurately estimated with standard CT and standard MR imaging.
CONCLUSION: More research must be performed to ascertain whether any relationship exists between the different types of HCC and the clinical outcome.

Entities:  

Mesh:

Year:  1994        PMID: 8029401     DOI: 10.1148/radiology.192.2.8029401

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Stepwise carcinogenesis of hepatocellular carcinoma in a nodule surrounded by hyperplastic and hypervascular liver tissue.

Authors:  Zenichi Morise; Atsushi Sugioka; Yoshikazu Mizoguchi; Ryoichi Kato; Yoshinao Tanahashi
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

2.  Ciliated foregut cyst in cirrhotic liver.

Authors:  T Murakami; A Imai; H Nakamura; K Tsuda; T Kanai; K Wakasa
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.

Authors:  Kojiro Taura; Iwao Ikai; Etsuro Hatano; Hideaki Fujii; Naoki Uyama; Yasuyuki Shimahara
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

Review 4.  [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].

Authors:  A Ba-Ssalamah; B Happel; J Kettenbach; A Dirisamer; F Wrba; F Längle; W Schima
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

5.  Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.

Authors:  M Mandai; M Koda; T Matono; T Nagahara; T Sugihara; M Ueki; K Ohyama; Y Murawaki
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

Review 6.  Screening for hepatocellular carcinoma: why, when, how?

Authors:  Miguel R Arguedas
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 7.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

8.  Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.

Authors:  Masahiko Koda; Yoshiko Matsunaga; Masaru Ueki; Yoshiko Maeda; Ken-ichi Mimura; Kinya Okamoto; Keiko Hosho; Yoshikazu Murawaki
Journal:  Eur Radiol       Date:  2003-12-16       Impact factor: 5.315

9.  Early hepatocellular carcinoma: three-phase helical CT features of 16 patients.

Authors:  Jongmee Lee; Won Jae Lee; Hyo Keun Lim; Jae Hoon Lim; Nami Choi; Mi-hyun Park; Sang Won Kim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2008 Jul-Aug       Impact factor: 3.500

10.  Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.

Authors:  Azza E I El-Bassiouny; Mona M K Zoheiry; Mona M F Nosseir; Eman G El-Ahwany; Raafat A Ibrahim; Nora E I El-Bassiouni
Journal:  MedGenMed       Date:  2007-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.